Organization | Cheikh Anta Diop University, Senegal

Cheikh Anta Diop University, Senegal Report issue

Academic/Hospital Phase 3 Phase 4

Founded: Dakar Senegal (1957)

Organization Overview

First Clinical Trial

2002

NCT00132561

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Cheikh Anta Diop University, Senegal

Active Ingredients

Drugs in Phase 4 Trials (4)

amodiaquine (camoquin) (6 trials)

pyrimethamine (daraprim) (7 trials)

sulfadoxine (7 trials)

zn2+ (2 trials)

Drugs in Phase 3 Trials (5)

artesunate (2 trials)

coartem (1 trial)

dihydroqinghaosu (1 trial)

lumefantrine (Coartem) (1 trial)

piperaquinoline (1 trial)

Drugs in Other Trials (3)

tenofovir (viread) (1 trial)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malaria (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 14
# of Trial APIs: 12